RT Journal Article
SR Electronic
T1 A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000530
DO 10.1136/jitc-2020-000530
VO 8
IS 1
A1 Naing, Aung
A1 Gainor, Justin F
A1 Gelderblom, Hans
A1 Forde, Patrick M
A1 Butler, Marcus O
A1 Lin, Chia-Chi
A1 Sharma, Sunil
A1 Ochoa de Olza, Maria
A1 Varga, Andrea
A1 Taylor, Matthew
A1 Schellens, Jan H M
A1 Wu, Hongqian
A1 Sun, Haiying
A1 Silva, Antonio P
A1 Faris, Jason
A1 Mataraza, Jennifer
A1 Cameron, Scott
A1 Bauer, Todd M
YR 2020
UL http://jitc.bmj.com/content/8/1/e000530.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.